As of Feb 20
| -0.06 / -0.12%|
The 11 analysts offering 12-month price forecasts for Encompass Health Corp have a median target of 57.00, with a high estimate of 60.00 and a low estimate of 48.00. The median estimate represents a +9.53% increase from the last price of 52.04.
The current consensus among 13 polled investment analysts is to Buy stock in Encompass Health Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.